KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Net Cash Flow: 2009-2025

Historic Net Cash Flow for Charles River Laboratories International (CRL) over the last 17 years, with Sep 2025 value amounting to $27.5 million.

  • Charles River Laboratories International's Net Cash Flow rose 19.98% to $27.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.9 million, marking a year-over-year decrease of 110.37%. This contributed to the annual value of -$61.4 million for FY2024, which is 274.43% down from last year.
  • According to the latest figures from Q3 2025, Charles River Laboratories International's Net Cash Flow is $27.5 million, which was up 146.12% from -$59.7 million recorded in Q2 2025.
  • Charles River Laboratories International's 5-year Net Cash Flow high stood at $227.0 million for Q1 2021, and its period low was -$249.6 million during Q2 2021.
  • Over the past 3 years, Charles River Laboratories International's median Net Cash Flow value was $7.4 million (recorded in 2024), while the average stood at -$3.4 million.
  • Its Net Cash Flow has fluctuated over the past 5 years, first skyrocketed by 311.29% in 2021, then crashed by 314,771.43% in 2024.
  • Charles River Laboratories International's Net Cash Flow (Quarterly) stood at $19.6 million in 2021, then surged by 54.06% to $30.2 million in 2022, then spiked by 251.64% to $106.1 million in 2023, then plummeted by 93.05% to $7.4 million in 2024, then climbed by 19.98% to $27.5 million in 2025.
  • Its last three reported values are $27.5 million in Q3 2025, -$59.7 million for Q2 2025, and $20.9 million during Q1 2025.